Insider Trading - Bitterman Kevin

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Bitterman Kevin

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2016-12-05
Sale
2016-12-07
4:43 pm
Editas Medicine Inc. EDIT Bitterman Kevin
Director
10% Owner
130,000 $15.79 $2,052,700 3,872,144
(Indirect)
View
2016-12-07
Sale
2016-12-08
5:07 pm
Editas Medicine Inc. EDIT Bitterman Kevin
Director
10% Owner
75,000 $15.82 $1,186,500 3,797,144
(Indirect)
View
2017-05-22
Sale
2017-05-24
4:38 pm
Editas Medicine Inc. EDIT Bitterman Kevin
Director
1,000,000 $17 $17,000,000 2,797,144
(Indirect)
View
2019-06-24
Purchase
2019-06-25
6:06 pm
Akero Therapeutics Inc. AKRO Bitterman Kevin
Director
270,000 $16 $4,320,000 505,099
(Indirect)
View
2020-10-09
Sale
2020-10-14
4:54 pm
Akero Therapeutics Inc. AKRO Bitterman Kevin
Director
13,000 $28.93 $376,090 2,523,075
(Indirect)
View
2021-06-01
Sale
2021-06-03
8:07 pm
Akero Therapeutics Inc. AKRO Bitterman Kevin
Director
17,489 $26.28 $459,611 2,232,251
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2017-06-15
Option Award
2017-06-19
4:36 pm
N/A
2027-06-14
Editas Medicine Inc. EDIT Bitterman Kevin
Director
11,538 $0 11,538
(Direct)
View
2019-06-24
Conversion
2019-06-25
6:06 pm
N/A
N/A
Akero Therapeutics Inc. AKRO Bitterman Kevin
Director
15,094,262 $0 505,099
(Indirect)
View
2019-11-08
Option Award
2019-11-12
7:02 pm
N/A
2029-11-07
Akero Therapeutics Inc. AKRO Bitterman Kevin
Director
26,000 $0 26,000
(Direct)
View
2020-06-01
Option Award
2020-06-02
6:54 pm
N/A
2030-05-31
Akero Therapeutics Inc. AKRO Bitterman Kevin
Director
13,000 $0 13,000
(Direct)
View
2021-06-01
Option Award
2021-06-03
5:56 pm
N/A
2031-05-31
Akero Therapeutics Inc. AKRO Bitterman Kevin
Director
13,000 $0 13,000
(Direct)
View